BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23496910)

  • 1. Experience and challenges from clinical trials with malaria vaccines in Africa.
    Mwangoka G; Ogutu B; Msambichaka B; Mzee T; Salim N; Kafuruki S; Mpina M; Shekalaghe S; Tanner M; Abdulla S
    Malar J; 2013 Mar; 12():86. PubMed ID: 23496910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustainable development of a GCP-compliant clinical trials platform in Africa: the malaria clinical trials alliance perspective.
    Ogutu BR; Baiden R; Diallo D; Smith PG; Binka FN
    Malar J; 2010 Apr; 9():103. PubMed ID: 20406478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of anti-malarial vaccines and need for clinical trials in accordance with international standards in South Africa].
    Doumbo OK; Djimdé AA; Théra MA
    Bull Soc Pathol Exot; 2008 Jun; 101(3):249-53. PubMed ID: 18681219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa.
    Mamotte N; Wassenaar D; Koen J; Essack Z
    BMC Med Ethics; 2010 Mar; 11():3. PubMed ID: 20211030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EDCTP regional networks of excellence: initial merits for planned clinical trials in Africa.
    Miiro GM; Oukem-Boyer OO; Sarr O; Rahmani M; Ntoumi F; Dheda K; Pym A; Mboup S; Kaleebu P;
    BMC Public Health; 2013 Mar; 13():258. PubMed ID: 23517572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding protective immune mechanisms induced by malaria vaccines in the context of clinical trials.
    Dobaño C; Campo JJ
    Hum Vaccin; 2009 Aug; 5(8):562-5. PubMed ID: 19287202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative decline in funding of European Commission malaria vaccine projects: what next for the European scientists working in this field?
    Thøgersen RL; Holder AA; Hill AV; Arnot DE; Imoukhuede EB; Leroy O
    Malar J; 2011 Sep; 10():255. PubMed ID: 21880156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Equatoguinean Malaria Vaccine Initiative: From the Launching of a Clinical Research Platform to Malaria Elimination Planning in Central West Africa.
    Billingsley PF; Maas CD; Olotu A; Schwabe C; García GA; Rivas MR; Hergott DEB; Daubenberger C; Saverino E; Chaouch A; Embon O; Chemba M; Nyakarungu E; Hamad A; Cortes C; Schindler T; Mpina M; Mtoro A; Sim BKL; Richie TL; McGhee K; Tanner M; Obiang Lima GM; Abdulla S; Hoffman SL; Ayekaba MO
    Am J Trop Med Hyg; 2020 Sep; 103(3):947-954. PubMed ID: 32458790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical malaria vaccine development.
    Sauerwein RW
    Immunol Lett; 2009 Feb; 122(2):115-7. PubMed ID: 19100773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical development of malaria vaccines: should earlier trials be done in malaria endemic countries?
    Chilengi R
    Hum Vaccin; 2009 Sep; 5(9):627-36. PubMed ID: 19617708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research partnerships to solve health problems.
    Fleck F
    Bull World Health Organ; 2016 Jan; 94(1):8-9. PubMed ID: 26769991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of malaria vaccine efficacy in phase III trials: report of a WHO consultation.
    Moorthy V; Reed Z; Smith PG;
    Vaccine; 2007 Jul; 25(28):5115-23. PubMed ID: 17577487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community perceptions of a malaria vaccine in the Kintampo districts of Ghana.
    Febir LG; Asante KP; Dzorgbo DB; Senah KA; Letsa TS; Owusu-Agyei S
    Malar J; 2013 May; 12():156. PubMed ID: 23651533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 2020 vision for vaccines against HIV, tuberculosis and malaria.
    Rappuoli R; Aderem A
    Nature; 2011 May; 473(7348):463-9. PubMed ID: 21614073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials in sub-Saharan Africa and established standards of care: a systematic review of HIV, tuberculosis, and malaria trials.
    Kent DM; Mwamburi DM; Bennish ML; Kupelnick B; Ioannidis JP
    JAMA; 2004 Jul; 292(2):237-42. PubMed ID: 15249573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infectious disease: Beating the big three.
    Bourzac K
    Nature; 2014 Mar; 507(7490):S4-7. PubMed ID: 24611168
    [No Abstract]   [Full Text] [Related]  

  • 18. Malaria vaccine: a step toward elimination.
    Jindal H; Bhatt B; Malik JS; Sk S; Mehta B
    Hum Vaccin Immunother; 2014; 10(6):1752-4. PubMed ID: 24643280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines against malaria: perspectives from Papua New Guinea.
    Mueller I; Genton B; Betuela I; Alpers MP
    Hum Vaccin; 2010 Jan; 6(1):17-20. PubMed ID: 20173407
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.